Prostate cancer waiting times could be radically cut by an ‘extremely encouraging’ 20 minute test, scientists have revealed. The new ultrasound test can detect the vast majority of tumours and ...

The process uses existing ultrasound equipment which is ... Instead, the onus is on men to request a prostate specific antigen (PSA) blood test from their GP once they are over 50.

The new imaging test begins by injecting ... the patient’s bloodstream to the prostate. The team uses a technique known as super resolution ultrasound imaging (SRUI) to track these microbubbles ...

Using existing ultrasound equipment instead of expensive MRI scanners, the test could lead to early prostate cancer detection and prove to be cost-effective for patients. The new technique has ...

Every two minutes, a man is diagnosed with prostate cancer in our country. This disease is currently the second-leading cancer-related killer of men in the United States.

The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...

The test can differentiate between various grades of cancer, helping men avoid unnecessary biopsies. Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies.

Q: Is it possible to treat prostate cancer with sound waves? A: High-intensity focused ultrasound is an innovative treatment option for men with localized, low to intermediate-risk prostate cancer.

Presently, the typical test – known as a prostate specific antigen (PSA ... too late for curative treatment. By integrating ultrasound more prominently into the diagnostic pathway, we can ...

The ultrasound image highlights changed blood ... reducing the number of people sent for unnecessary and often risky tests." Prostate cancer is not always life-threatening and can be cured if ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the clinical ...